Ueda K, Takura T, Fujikoshi S, Meyers J, Nagar SP, Enomoto H. Long-term pain management and health care resource use among an employed population in Japan with knee osteoarthritis combined with low back pain. Pain Med. 2021 Dec 11;22(12):3041-50. doi: 10.1093/pm/pnaa424
Wise LA, Willis SK, Mikkelsen EM, Wesselink AK, Sorensen HT, Rothman KJ, Tucker KL, Trolle E, Vinceti M, Hatch EE. The association between seafood intake and fecundability: analysis from two prospective studies. Nutrients. 2020 Jul 29;12(8):E2276. doi: 10.3390/nu12082276
Marsh K, Moeller J, Basarir H, Orfanos P, Detzel P. The economic impact of lower protein infant formula for the children of overweight and obese mothers. Nutrients. 2016 Jan 2;8(1):18. doi: 10.3390/nu8010018
Arnold L, Crofford L, Martin SA, Young J, Sharma U. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med. 2007 Nov;8(8):633-8.
Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007 Sep 1;8(Suppl 2):S50-62.
Walker EA, Picker MJ, Granger AL, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther. 2004 Jul;310(1):150-8.
Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.
Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.